RENOVIS
Renovis, Inc. is a biopharmaceutical company developing drugs to treat neurological diseases and disorders. The Company is currently developing products for acute ischemic stroke, for the treatment of neuropathic pain, and for the treatment of acute post-operative pain.
RENOVIS
Industry:
Innovation Management Medical Professional Services
Founded:
2000-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.renovis.com
Total Employee:
11+
Status:
Active
Contact:
(909)557-2360
Total Funding:
84.2 M USD
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail PHP Apache 2.4 Hetzner CentOS Salesforce SPF
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
CDIB BioScience Ventures
CDIB BioScience Ventures investment in Series E - Renovis
HealthCap
HealthCap investment in Series E - Renovis
MDS Capital
MDS Capital investment in Series E - Renovis
Invus
Invus investment in Series E - Renovis
Easton Capital
Easton Capital investment in Series E - Renovis
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series B - Renovis
International BM Biomedicine Holdings AG
International BM Biomedicine Holdings AG investment in Series B - Renovis
Flagship Pioneering
Flagship Pioneering investment in Series B - Renovis
Venrock
Venrock investment in Series B - Renovis
Yasuda Enterprise Development
Yasuda Enterprise Development investment in Series B - Renovis
Official Site Inspections
http://www.renovis.com
- Host name: 80-92-65-188.ip.dclux.com
- IP address: 80.92.65.188
- Location: Luxembourg
- Latitude: 49.4986
- Longitude: 5.9784
- Timezone: Europe/Luxembourg
More informations about "Renovis"
Renovis Health
Renovis Choice Company (“Renovis”) partners with organizations that lead the nation in: lean management, patient quality servicing, customizing medical technology, providing quality …See details»
Renovis Health
Renovis specializes in building cohesive relationships with medical professionals and civic organizations to improve coordinated care and address the clinical and social needs of Medicare beneficiaries.See details»
Q&A: Renovis Health’s CEO, Reginald Euburuche, M.D.
Jul 27, 2023 · Renovis’ care model places great emphasis on enabling quality driven medicine to underserved and disenfranchised communities and elderly populations.See details»
Renovis - Crunchbase Company Profile & Funding
Renovis, Inc. is a biopharmaceutical company developing drugs to treat neurological diseases and disorders. The Company is currently developing products for acute ischemic stroke, for the treatment of neuropathic pain, and …See details»
Renovis - Products, Competitors, Financials, Employees, …
Jun 12, 2016 · Renovis is a biopharmaceutical company that seeks to improve the lives of patients suffering from neurological disease with novel drugs that renew, restore, and repair …See details»
Renovis Health Partners with Innovaccer to Accelerate …
Jun 6, 2023 · Renovis Health is a fast-growing ACO REACH provider organization licensed to take on risk for Medicare lives in all 50 states. Its providers include primary care physicians specializing in...See details»
Renovis Health Partners with Innovaccer to Accelerate …
Jun 6, 2023 · Renovis Health is a fast-growing ACO REACH provider organization licensed to take on risk for Medicare lives in all 50 states. Its providers include primary care physicians specializing in treating patients with …See details»
Renovis Health Partners with Innovaccer to Accelerate …
Jun 15, 2023 · Innovaccer Inc. recently announced that Renovis Health, a Medicare Accountable Care Organization Realizing, Equity, Access, and Community Health ("ACO REACH") provider headquartered in...See details»
Renovis Inc - Company Profile and News - Bloomberg Markets
Renovis, Inc. is a biopharmaceutical company developing drugs to treat neurological diseases and disorders. The Company is currently developing products for acute ischemic stroke, for the...See details»
Renovis Company Profile 2024: Valuation, Investors, Acquisition
Information on acquisition, funding, investors, and executives for Renovis. Use the PitchBook Platform to explore the full profile.See details»
Renovis, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Renovis, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 7 news, and 21 literature, Technology Platform:Small molecule drug, Drug:RN-9893, RN-1747, …See details»
Evotec to Acquire Renovis, Seek NASDAQ Listing
Hamburg, Germany | South San Francisco, California - Evotec AG (Frankfurt Stock Exchange: EVT) and Renovis, Inc. (NASDAQ: RNVS) today announced that they have entered into a …See details»
Surgeons Cash In on Stakes in Private Medical Device Companies
Nov 17, 2015 · Hundreds of orthopedists and neurosurgeons have cashed in on stakes in companies that design, manufacture or distribute orthopedic implants — sometimes after …See details»
Evotec Completes Acquisition of Renovis
Hamburg, Germany and South San Francisco, CA - Evotec AG (Frankfurt Stock Exchange: EVT) today announced that the merger has been successfully completed and that Renovis, Inc. …See details»
Renovis Surgical Technologies - Crunchbase
Renovis Surgical Technologies, Inc. develops, manufactures, and sells orthopedic medical implants to surgeons and hospitals. Its products include tapered cement less hip systems, …See details»
KYOCERA to Purchase Major Assets of U.S. - based Renovis …
Jan 16, 2019 · Technologies, Inc. (herein “Renovis”), a U.S.-based orthopedic and spinal medical device manufacturer and developer, to purchase the major assets of Renovis’ business …See details»
How surgeons have cashed in with private ortho companies that …
Aug 10, 2021 · Several orthopedic surgeons who invested in Renovis Surgical Technologies made big money when a Japanese technology giant snatched up the small California medical …See details»
KYOCERA to Purchase Major Assets of U.S.-based Renovis Surgical ...
Jan 16, 2019 · Renovis, founded in 2009, is a market leader in 3D-printed implants, and has developed a broad portfolio of innovative products for the U.S. market, serving the needs of …See details»
Kyocera Expands U.S. Ortho Presence With Renovis Purchase
Jan 22, 2019 · Japan-based Kyocera Corporation has announced that its U.S. headquarters, Kyocera International, Inc., has agreed to purchase the major assets of Renovis Surgical …See details»